Regulatory Document Quality Control Software: Buyer Guide

Assyro publishes this guide and is our first editorial recommendation to evaluate. Placement is not an independent accuracy ranking. In particular, Assyro's submission-validation capabilities do not establish automated reconciliation of every narrative statement against clinical source tables.

This guide is for medical-writing and QC leads reviewing clinical study reports, synopses, protocols, statistical analysis plans, and related summaries. The buying question is specific: which errors will the proposed workflow detect, and what evidence lets a reviewer resolve them? A document can be grammatically sound, correctly formatted, and technically publishable while reporting the wrong treatment arm's result.

Shortlist by the review job you need done

These four candidates represent different ways to support document QC. They are not interchangeable detectors. A source-verification requirement can exclude an editorial tool from the primary purchase while leaving it useful as an adjunct.

The comparison uses public vendor documentation checked on October 6, 2026, plus Assyro's product-status records for our own claims. We did not run a comparative software trial. Public pages do not establish the installed build, licensed checks, parser coverage, or detection performance for your documents. The exercise below is an original synthetic procurement example, not reported vendor output.

Separate five meanings of “quality control”

Before sending an RFP, classify the error you need to prevent. Otherwise, two vendors can truthfully answer “yes, we provide QC” while offering different deliverables.

FDA's Specifications for eCTD v4.0 Validation Criteria, version 1.6 dated August 2026, contains schema, business-rule, submission-package, and PDF checks. Its scope is not a claim that every scientific sentence has been reconciled with its underlying analysis. Treating a technical pass as proof of narrative accuracy goes beyond what that evidence establishes. See the FDA criteria, revision history and section 2.

The word “source” also needs definition. In this guide, it means the approved material used to support the document: for example, a protocol, statistical analysis plan, or tables, listings, and figures (TLFs, also called TFLs). It does not mean the software has independently verified the original clinical records or rerun the statistical analysis.

If the purchase also includes package checks, use the eCTD validation software comparison to define that separate acceptance track. A tool can meet the technical criteria and still need another review method for narrative accuracy.

For numerical checks, matching a number is only part of the task. The reviewer needs the treatment, population, time point, endpoint, unit, analysis method where relevant, and source version. A tool that finds “12.5%” somewhere in the uploaded files has not necessarily established that the sentence is correct.

Four products to evaluate, with different acceptance tests

Assyro: evaluate the connection between document review and submission work

Assyro is the starting candidate when the purchase spans document preparation, review, and submission readiness. Our public product overview describes a shared submission workspace; our documented product scope includes document management and FDA eCTD 4.0 workflows. That makes the handoff from a corrected document into submission preparation a relevant evaluation path.

For this particular buying decision, require a separate demonstration of source QC. We have not established in this comparison that Assyro automatically catches every numerical or contextual discrepancy in an imported CSR, nor that it reconciles an arbitrary set of external documents. Those remain eligibility questions when automated checking is mandatory.

Bring one document with a disputed statement and the approved table that resolves it. Ask the demonstrator to distinguish what the software identifies automatically from what a human reviewer identifies. Follow the issue through correction and export. Inspect whether the original finding, source identity, reviewer explanation, and corrected version remain connected in the proposed workflow.

Then change the source version. The consequential question is whether earlier review evidence still appears current or whether the affected work is visibly reopened. A polished document list cannot answer that question.

Assyro is worth evaluating when a team wants review work to inform submission preparation. If your immediate requirement is unattended CSR-to-TLF checking, keep that requirement as a firm purchase condition. An integrated workflow is useful only if the demonstrated checking scope and remaining human effort match your operating model. Confirm supported submission formats separately if publishing is also part of the purchase.

GenInvo DocQC: examine the individual checks and their exclusions

GenInvo describes DocQC as a configurable medical-writing QC tool. Its product page names an In-text Match Post-text check for CSR data/text against referenced tables and CSR Match Protocol SAP for methods sections. It also lists PDF and DOCX inputs. These are concrete reasons to include it for clinical source reconciliation.

The same page exposes an important boundary: Post-text TFL Content excludes post-text TFLs referenced within in-text tables. Its Multiple Documents Keyword Check describes displaying relevant content using keywords; that wording alone does not establish automatic semantic contradiction detection. Ask which check covers your exact document relationship.

Use the source pack below to challenge placement as well as content. Put a discrepancy in narrative text, then put an equivalent reference inside an embedded table. Request the check name and result for each location. A vendor should be able to explain a supported difference in coverage without labeling an unexamined passage “passed.”

Implementation also has two distinct commercial paths. GenInvo's 2026 product-event overview describes a service model in which its team delivers documents and a licensing model in which the client operates DocQC. Establish which one your proposal contains. In a service engagement, reviewer expertise and turnaround belong in the acceptance criteria; in a software purchase, configuration ownership and training need explicit allocation.

DocQC is a relevant candidate when the backlog consists of repeated clinical-document comparisons. Before signing, retain a sample report with check coverage, unresolved findings, and source references. Confirm who maintains study-specific rules when templates or source layouts change.

Certara CoAuthor: distinguish preventing drift from detecting it afterward

CoAuthor approaches consistency through authoring. Certara describes a Microsoft Word workflow with a governed repository of reusable content, source-directed generation, and version/traceability features. The repository is intended to keep recurring material such as study identifiers consistent across documents. That is a different intervention from inspecting a folder of independently authored reports after completion. See CoAuthor's product description.

Certara's current product description lists source-directed generation, traceability and version control. Treat those as documented product claims to examine in the proposed configuration. They are not an independent accuracy result or evidence that every externally inserted sentence receives equivalent checks. Ask the demonstrator to show the source relationship for both generated and imported text.

The decisive demo has two routes. First, create a paragraph through the supported source-based workflow. Second, paste an externally authored paragraph containing the same number with the wrong population. Ask the reviewer to inspect the evidence available in each route. If the controls differ, record that difference in your authoring procedure and purchase scope.

Also ask who approves reusable content and how updates reach documents already under review. A correct shared block can reduce repeated maintenance. An incorrectly approved block can distribute the same error widely, so consistency alone cannot establish truth.

The regulatory content reuse guide develops that approval-and-propagation decision. Compare Assyro's regulatory-writing workflow against the same source-version and human-review requirements when authoring is part of your scope.

CoAuthor belongs on the shortlist when the team can change how documents are created and reused. If the department receives finished CSRs from many external writers and wants a standalone detector, require that imported-document workflow to be demonstrated before assuming an authoring license solves the review backlog. Budget for template and content-governance work alongside the software.

PerfectIt: use editorial consistency as a distinct review pass

PerfectIt's official medical-writing demonstration shows checks for hyphenation, number presentation, abbreviations, and configurable terminology. Users inspect occurrences and choose corrections in Word. This is relevant to long documents assembled by several authors, where style decisions can drift between sections.

Source: PerfectIt's official correction guide. View original image. Vendor documentation demonstration, retrieved September 14, 2026; the exact patch release is unspecified. The screenshot shows editorial choices, not clinical source reconciliation or a run of this article's synthetic example.

The vendor's enterprise page states that PerfectIt for Windows operates locally and leaves decisions to the user. That Windows-specific deployment statement may matter to teams evaluating document-processing boundaries. Confirm the precise platform and any additional components in your proposed installation rather than extending that statement to every configuration.

The documented workflow does not establish reconciliation of a CSR result against its statistical source. Select it for the editorial workload it describes, and retain a separate source-review process when numerical or scientific accuracy is the buying requirement.

For its demo, deliberately include an approved abbreviation, a genuine undefined abbreviation, and a spelling difference inside a verbatim quotation. Check whether the reviewer can accept the real correction while preserving context-dependent exceptions. A tool that aggressively standardizes every difference can create new editorial work.

Rollout depends on maintaining the right style definitions for each sponsor or document family. Identify an owner for those rules, test them on representative files, and separate client preferences from scientific terminology that cannot be freely substituted. PerfectIt is a plausible adjunct when the scientific review process already works and repetitive editorial cleanup consumes reviewer attention; it should not earn credit for source checks outside its documented scope.

A synthetic discrepancy pack for vendor demonstrations

Use the following small, fictional study pack to make “checks consistency” observable. All identifiers, values, dates, and statements are invented for this exercise. The tables are the complete source record for the stated checks; they are not clinical evidence or a statistical analysis. No vendor has been run against this pack for this article.

Download the Q17 discrepancy exercise

Download the Q17 source pack, review passages and results worksheet. Revision 1.1, dated October 5, 2026, contains the same fictional sources and six cases below, a separate answer key and an unscored actual-results CSV. Give the demonstrator the source records and review passages; keep the answer key separate from observed findings. The combined review-and-answer CSV is a facilitator reference, not evidence that a product found the errors.

The pack contains four seeded errors, one legitimate population difference and one unsupported claim. Record actual coverage and reviewer decisions, then retain both original and corrected-run reports. A blank result is “not evaluated,” never a successful detection.

Establish the approved sources

Assume study Q17 has the following approved records. All draft results refer to the final June 30 cutoff unless explicitly labeled otherwise. “Participants with an event” counts people, not the total number of events.

The correct final safety percentages are 20.7% for active treatment and 15.0% for placebo, rounded to one decimal place: 12 ÷ 58 × 100 and 9 ÷ 60 × 100. A reviewer can calculate these directly, but the software must still associate each number with the correct arm and population.

Insert these passages into the review copies

Keep the source records unchanged. The “copy location” column specifies where to place each invented statement; it is not a product-specific input format.

Case E is as consequential as the seeded errors. A system that replaces 118 with 120 to make every population count match has introduced an error. If it initially flags the difference for a human, inspect whether the reviewer can record the rationale and preserve both values. That is different from calling the difference a confirmed defect.

Case B separates numerical accuracy from source authority. The old percentage is internally correct. A tool must know which cutoff the sentence claims and which version supports it; simply finding a matching number in the repository can produce false reassurance.

Retain the evidence behind each finding

For every case, request the reviewed passage, source version and location, relevant population/cutoff, finding rationale, disposition, and corrected output where a correction is warranted. Also request an inventory of the files and sections the tool actually read. A scanned table that could not be parsed must not disappear into an overall green status.

Record results as detected, missed, flagged for review, or not evaluated. Count the seeded errors and intentional difference separately. Do not turn this tiny fixture into a general accuracy percentage: it tests six specified situations, not the distribution of errors in your portfolio.

Finally, fix A through D, retain E, and leave F unresolved pending its source. Repeat the review. The corrected passages should no longer produce the original findings, the legitimate difference should remain acceptable, and the missing evidence should remain visible. Keep the first report as well as the rerun so a reviewer can see what changed.

Add the source-version handoff to your EDMS evaluation

Bind each review run to the exact document and source versions it examined. A useful run record contains the document ID/revision, source IDs/revisions, selected checks and tool version, processing exceptions, findings, reviewer decisions and exported output identity. This is a proposed operating record, not a claim that every listed product supplies it automatically.

For study Q17, record that the final safety check used Table14.3 version2. If version3 arrives after the review, retain the earlier result as evidence for the earlier baseline and assess affected statements again. Do not display the old result as a review of version3 merely because a repository link now opens the latest source.

Exercise that boundary before selection. Give a second reviewer the exported report and corrected document, then ask which source version supports the20.7% result and which missing evidence remains unresolved. If the report identifies only a filename that can refer to several versions, keep the source-traceability requirement Unknown until the workflow demonstrates an unambiguous relationship.

The quality-to-regulatory traceability guide explains the broader chain into submission work. Keep QC acceptance distinct from document approval and from technical package validation; each decision needs evidence appropriate to its purpose.

When separate checks pass but the documents conflict

Suppose the synopsis says 119 treated participants and the CSR says 118. Both files open, both links work, and neither contains a spelling error. Each can pass those individual checks because those checks do not compare the underlying claim across documents.

The immediate issue is the conflicting count. The demonstrated coverage gap is that no successful comparison of those two claims has been shown. An upstream cause—such as reuse of an old draft—remains a hypothesis until version records support it. Do not blame the authoring tool or declare a parser defect without that evidence.

Resolve the count against the approved population definition and source table, then identify every downstream statement using that result. The durable control is a review boundary that requires the same fact's context and source to be reconciled across the relevant documents. It can be automated, assisted, or manual; its coverage must be explicit.

This also changes procurement. Require a product claiming cross-document QC to demonstrate case D with both files present. Two clean single-file reports cannot satisfy that requirement. If the tool only surfaces matching keywords, include the human comparison effort in the operating model.

Choose the workflow for your actual backlog

A small team connecting review to submission preparation: evaluate Assyro first with the source pack and a representative correction-to-export handoff. Make source-check coverage a purchase condition, and retain specialist or manual review for any unproven checks.

A medical-writing group receiving completed CSRs: prioritize GenInvo DocQC's named comparisons after the initial shortlist review. Verify imported-file coverage and distinguish a software license from an outsourced QC service. Existing document layouts are likely to matter more than a vendor's clean demonstration template.

A team creating many related documents from shared content: evaluate CoAuthor's authoring controls. Challenge how externally edited passages and changed sources are handled. The investment is in a controlled creation process as well as review support.

A department with a sound scientific-review process and heavy editorial cleanup: evaluate PerfectIt as an adjunct. Its task is applying editorial conventions while reviewers retain responsibility for evidence and interpretation.

For a different use case, broaden the field deliberately. Florence DocQC is a separate product from GenInvo DocQC: Florence describes checks such as blank, duplicate, missing, and unreadable pages at upload into eBinders/eTMF. That is relevant to trial-document intake, rather than evidence here of CSR-to-TLF reconciliation. Similar product names should not merge into one procurement requirement.

Put coverage, review effort, and handoff in the proposal

Ask vendors to price the same workload: document types, typical sizes, source formats, annual volume, users, concurrent reviewers, and required turnaround. No comparable configured quotes were verified for this guide, so it does not assign price bands or a lowest-cost winner.

Separate recurring license or usage fees from configuration, source preparation, training, supplier assessment, and your own review effort. If a service is included, identify its deliverables and revision allowance. A low processing fee can be outweighed by time spent mapping tables or dismissing findings; a broad platform license may include capabilities your QC team will not use.

Use this evidence checklist with the proposed configuration:

Make the handoff a real part of the demo. Have a second reviewer open the exported result without relying on the original operator's explanation. That person should be able to locate an unresolved issue, inspect the supporting source, and understand why the two legitimate population totals remain different.

Bring the synthetic pack and one representative document to an Assyro evaluation discussion. Ask for the checking scope, human review steps, and output evidence to be shown together. Use the same acceptance cases for every candidate so the purchase follows demonstrated coverage of your review problem.